Sexual health

STI Screening for Women: A Schedule by Age

Save

The core STI panel for women is chlamydia, gonorrhea, HIV, and syphilis, with hepatitis and trichomoniasis added by risk. Sexually active women under 25 are advised to test yearly for chlamydia and gonorrhea; cervical screening runs separately, with a Pap about every 3 years from 21. Frequency after 25 depends on partners and risk.

Last updated: July 2026

Talk to a clinician

A primary-care clinician

Gale can help you find one in your state and request a visit.

Find care →

Which STI tests do women actually need?

The core screening set for women covers chlamydia, gonorrhea, HIV, and syphilis, with hepatitis and trichomoniasis added based on individual risk. Which tests you need and how often depend on age, sexual activity, pregnancy, and risk factors rather than a single universal schedule. The World Health Organization recommends routine STI screening as part of standard sexual-health care and notes that self-collected samples work well for several infections 1. Cervical screening for HPV, though aimed at preventing cancer, is part of the same well-woman picture and follows its own timetable 2. Because many infections cause no symptoms, testing without symptoms is normal and expected rather than a sign something is wrong.

What is the STI screening schedule by age?

Age shapes the screening schedule more than any other single factor. For sexually active women under 25, yearly chlamydia and gonorrhea testing is standard public-health guidance, because these infections are most common in this group and often silent. From 25 onward, the same tests are advised when risk factors are present, such as a new partner, multiple partners, or a partner with an infection. Cervical screening follows its own clock: a Pap test about every 3 years from age 21, or HPV-based testing about every 5 years from age 30 to 65 2. A one-time HIV test is advised for everyone aged 13 to 64, repeated when ongoing risk is present.

How often should you test if you are sexually active?

Frequency depends on partners and risk, not the calendar alone. Someone with one long-term, mutually exclusive partner may need testing only occasionally, while new partners, multiple partners, or a partner's diagnosis call for testing more often — commonly every 3 to 6 months in higher-risk situations. Because timing affects accuracy, a test done too soon after exposure can miss an infection, and re-testing after a window period improves reliability 1. Home and clinic options both exist, so understanding how often to get tested and what a full STI panel covers helps you ask for the right tests. Guidelines recommend matching frequency to actual exposure rather than a fixed number.

What about HPV, Pap tests, and vaccination?

HPV screening and vaccination sit alongside STI testing as core prevention. Cervical screening looks for HPV and precancerous changes rather than symptoms, which is why it runs on a fixed schedule regardless of how you feel 2. Vaccination is the upstream defense: in a landmark trial, the HPV vaccine sharply reduced high-grade cervical lesions in women aged 15 to 26 3, and it is now offered to adults into their mid-40s. Routine screening and vaccination together have driven cervical precancer rates down over the past two decades. Keeping cervical screening current is one of the highest-value habits in a woman's prevention plan, according to major professional guidance 2.

When STI screening needs a clinician's plan

A personalized screening plan is worth building with a primary care clinician or gynecologist, who can match tests and timing to your life rather than a generic list. A clinician can order the right panel, interpret a positive result, and advise on partner notification and re-testing. A result that comes back positive is common and treatable, and a clinician can arrange partner treatment so an infection does not simply bounce back. Screening needs shift across the lifespan: adolescence and the early sexually active years carry the highest chlamydia and gonorrhea rates, pregnancy adds its own required tests, and midlife brings renewed attention to cervical screening and HPV. A well-woman visit is the natural place to review all of it in one appointment 4. Gale can help you prepare the questions that make that visit efficient.

Common questions

A common baseline covers chlamydia, gonorrhea, HIV, and syphilis. Depending on your risk and symptoms, a clinician may add hepatitis B and C, trichomoniasis, or herpes testing. Cervical screening for HPV is related but separate, since it aims to prevent cancer rather than diagnose an active infection.

Yes. Many sexually transmitted infections, including chlamydia and gonorrhea, often cause no symptoms at all, which is exactly why routine screening exists. Testing without symptoms is normal and is the only reliable way to catch a silent infection before it can spread or be passed on.

It depends on your age and risk. Sexually active women under 25 are generally advised to test yearly for chlamydia and gonorrhea. With new or multiple partners, more frequent testing, often every three to six months, is reasonable. A clinician can set a schedule that fits your situation.

No. A Pap smear checks cervical cells for precancerous changes and, often, for HPV, while STI tests look for specific infections like chlamydia or HIV. They are sometimes done at the same visit, but a normal Pap does not mean you have been screened for other STIs.

Related

Say it back

How would you explain this to someone you love?

Two or three sentences, just as you’d say it. Gale reflects back what you focused on — a mirror, not a quiz.

Talk to a clinician

A primary-care clinician

Gale can help you find one in your state and request a visit.

Find care →

When to build a screening plan with a clinician

  • Pelvic or lower-abdominal pain, fever, or unusual bleeding can signal a spreading infection and is a reason to seek prompt clinician care.
  • A partner who tests positive for an STI is a reason to seek testing and clinician advice, even without symptoms.
  • Sores, unusual discharge, or pain with urination are reasons to seek clinician review and testing.
  • A positive test result is a reason to seek clinician treatment and arrange partner testing.

This article is general health education, not medical advice. Your personal screening schedule should be set with a primary care clinician or gynecologist based on your age, history, and risk factors.

References

  1. 1.World Health Organization (2022). WHO guideline on self-care interventions for health and well-being, 2022 revision. World Health Organization (WHO). linkSupports routine STI screening as part of standard sexual-health care and the validity of self-collected samples and window-period re-testing.
  2. 2.American College of Obstetricians and Gynecologists (2016). Practice Bulletin No. 168: Cervical Cancer Screening and Prevention. Obstetrics & Gynecology. doi:10.1097/AOG.0000000000001708Supports the cervical screening schedule — Pap testing about every 3 years from age 21 and HPV-based testing about every 5 years from age 30 to 65.
  3. 3.FUTURE II Study Group (2007). Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions. New England Journal of Medicine. doi:10.1056/NEJMoa061741Supports that the quadrivalent HPV vaccine sharply reduced high-grade cervical lesions in a landmark trial of women aged 15 to 26.
  4. 4.American College of Obstetricians and Gynecologists (2018). ACOG Committee Opinion No. 755: Well-Woman Visit. Obstetrics & Gynecology. doi:10.1097/AOG.0000000000002897Supports the well-woman visit as the setting to review age-based screening, including STI and cervical screening, across the lifespan.

4 sources, numbered by first appearance. General health information, not medical advice. AI-assisted editorial content — every citation independently verified. Editorial policy